MEAGAN WILSON: Open Payments
NPI 1881140598 · DAWSONVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,526 in 84 payments from 24 companies in 2025. Trend: 2023 $662 · 2024 $1,272 · 2025 $1,526
Food & beverage: $1,526
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 7 | $175 |
| Amgen Inc. | 11 | $175 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $151 |
| ABBVIE INC. | 16 | $142 |
| PFIZER INC. | 8 | $139 |
| Otsuka America Pharmaceutical, Inc. | 5 | $123 |
| Exact Sciences Corporation | 3 | $58 |
| Lundbeck LLC | 2 | $57 |
| Gilead Sciences, Inc. | 2 | $54 |
| Indivior Inc. | 3 | $52 |
Products named: REXULTI, FANAPT, OTEZLA, CAPLYTA, NURTEC ODT, VRAYLAR, Cologuard Collection Kit, SUBLOCADE.
Industry payments across GA — which companies pay providers there.
